News summary

The pharmaceutical sector fell this week, falling more than 9% year-to-date. Biological products, chemical pharmaceuticals and raw materials fell significantly. Jingfeng Pharmaceutical led the gains, while ST Jiyao and Guobang Pharmaceutical rose slightly.

Newsletter text

[The performance of pharmaceutical stocks lost momentum this week, and the index decline intensified] This week, the pharmaceutical stock market showed a volatile trend, with the overall decline being more obvious. From the beginning of the year to this week, the pharmaceutical index fell 2.5 percentkatsubetbonuscodes.12% and 9.40%, compared to the Shanghai Composite IndexkatsubetbonuscodesThe excess returns reached-2.44% and-16.59% respectively. Among the sub-sectors, the pharmaceutical business, traditional Chinese medicine, and medical services sectors experienced smaller declines, while the biological products, chemical pharmaceuticals and raw materials sectors faced larger price adjustments. Among the performance of specific stocks this week, Qianfengfeng Pharmaceutical recorded the largest increase, with an increase of 17.61%, followed by *ST Jiyao and Guobang Pharmaceutical, with increases of 8.94% and 7.11% respectively. However, at the same time, the share prices of several companies in the biological products, chemical pharmaceuticals and API sectors have experienced significant declines, reflecting the growing market concerns about these sub-areas.